Cargando…
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome
Coronavirus disease 2019 (COVID-19) is a rapidly expanding global pandemic caused by severe acute respiratory syndrome coronavirus 2, resulting in significant morbidity and mortality. A substantial minority of patients hospitalized develop an acute COVID-19 cardiovascular syndrome, which can manifes...
Autores principales: | Hendren, Nicholas S., Drazner, Mark H., Bozkurt, Biykem, Cooper, Leslie T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314493/ https://www.ncbi.nlm.nih.gov/pubmed/32297796 http://dx.doi.org/10.1161/CIRCULATIONAHA.120.047349 |
Ejemplares similares
-
Neprilysin Inhibitors in Heart Failure: The Science, Mechanism of Action, Clinical Studies, and Unanswered Questions
por: Bozkurt, Biykem, et al.
Publicado: (2022) -
COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases
por: Zhang, Yuanyuan, et al.
Publicado: (2021) -
Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus
por: Dimopoulos, Konstantinos, et al.
Publicado: (2023) -
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
por: Raman, Betty, et al.
Publicado: (2022) -
A Proposal for Integrated Efficacy-to-Effectiveness (E2E) Clinical Trials
por: Selker, H P, et al.
Publicado: (2014)